News

Japanese drugmaker Shionogi said on Wednesday that it will acquire Torii Pharmaceutical , a subsidiary of Japan Tobacco , for ...
Japan Tobacco Inc. ( OTCPK:JAPAY) Q1 2025 Results Conference Call May 7, 2025 6:00 AM ET Hiromasa Furukawa - Group Chief Financial Officer Dinesh Babu Thotakura - General Manager Nobuya Kato - JTI ...
Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...
Bain Capital bought Mitsubishi Tanabe Pharma for $3.5 billion while Blackstone acquired a majority stake in one of Japan’s ...
OSAKA/TOKYO -- Japanese drugmaker Shionogi said Wednesday that it will acquire Torii Pharmaceutical and other assets from Japan Tobacco in a deal worth around 160 billion yen ($1.1 billion), ...
Shionogi & Co. said it plans to acquire Japan Tobacco Inc. (JT) subsidiaries Torii Pharmaceutical Co. and Akros Pharma Inc. for ¥160 billion (US$1.1 billion) to expand its global R&D business. The two ...
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...
(RTTNews) - Japan Tobacco Inc. (JAPAF.PK, JAPAY.PK) on Wednesday posted higher profit in its first quarter, helped by higher revenues. The company also provided outlook for the year ahead.